These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 26149129

  • 1. Statin treatment alters serum n-3 to n-6 polyunsaturated fatty acids ratio in patients with dyslipidemia.
    Nozue T, Michishita I.
    Lipids Health Dis; 2015 Jul 07; 14():67. PubMed ID: 26149129
    [Abstract] [Full Text] [Related]

  • 2. Effects of statins on serum n-3 to n-6 polyunsaturated fatty acid ratios in patients with coronary artery disease.
    Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Michishita I.
    J Cardiovasc Pharmacol Ther; 2013 Jul 07; 18(4):320-6. PubMed ID: 23324995
    [Abstract] [Full Text] [Related]

  • 3. Comparison of effects of serum n-3 to n-6 polyunsaturated fatty acid ratios on coronary atherosclerosis in patients treated with pitavastatin or pravastatin undergoing percutaneous coronary intervention.
    Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I.
    Am J Cardiol; 2013 Jun 01; 111(11):1570-5. PubMed ID: 23497779
    [Abstract] [Full Text] [Related]

  • 4. Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease.
    Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I.
    Am J Cardiol; 2013 Jan 01; 111(1):6-11. PubMed ID: 23040588
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients.
    Ogata N, Fujimori S, Oka Y, Kaneko K.
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun 01; 29(4-6):321-4. PubMed ID: 20544514
    [Abstract] [Full Text] [Related]

  • 8. Significance of imbalance in the ratio of serum n-3 to n-6 polyunsaturated fatty acids in patients with acute coronary syndrome.
    Nishizaki Y, Shimada K, Tani S, Ogawa T, Ando J, Takahashi M, Yamamoto M, Shinozaki T, Miyauchi K, Nagao K, Hirayama A, Yoshimura M, Komuro I, Nagai R, Daida H.
    Am J Cardiol; 2014 Feb 01; 113(3):441-5. PubMed ID: 24326273
    [Abstract] [Full Text] [Related]

  • 9. Association of Fish Consumption-Derived Ratio of Serum n-3 to n-6 Polyunsaturated Fatty Acids and Cardiovascular Risk With the Prevalence of Coronary Artery Disease.
    Tani S, Takahashi A, Nagao K, Hirayama A.
    Int Heart J; 2015 May 13; 56(3):260-8. PubMed ID: 25902881
    [Abstract] [Full Text] [Related]

  • 10. Polyunsaturated Fatty Acid Impact on Clinical Outcomes in Acute Coronary Syndrome Patients With Dyslipidemia: Subanalysis of HIJ-PROPER.
    Arashi H, Yamaguchi J, Kawada-Watanabe E, Koyanagi R, Sekiguchi H, Mori F, Haruta S, Ishii Y, Murasaki S, Suzuki K, Yamauchi T, Ogawa H, Hagiwara N.
    J Am Heart Assoc; 2019 Aug 20; 8(16):e012953. PubMed ID: 31390907
    [Abstract] [Full Text] [Related]

  • 11. Do Statins Counteract the Effect of Antidiabetic Drugs? Results of the SCEAD Study.
    Tarim BA, Fici F, Tengiz I, Avunduk S, Ozcan Y, Faikoglu G, Ari E, Robles NR, Grassi G.
    Yonsei Med J; 2023 Mar 20; 64(3):175-180. PubMed ID: 36825343
    [Abstract] [Full Text] [Related]

  • 12. Effect of rosuvastatin or its combination with omega-3 fatty acids on circulating CD34(+) progenitor cells and on endothelial colony formation in patients with mixed dyslipidaemia.
    Chantzichristos VG, Agouridis AP, Moutzouri E, Stellos K, Elisaf MS, Tselepis AD.
    Atherosclerosis; 2016 Aug 20; 251():240-247. PubMed ID: 27415612
    [Abstract] [Full Text] [Related]

  • 13. Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels.
    Makariou SE, Liberopoulos EN, Agouridis AP, Challa A, Elisaf M.
    J Cardiovasc Pharmacol Ther; 2012 Dec 20; 17(4):382-6. PubMed ID: 22431864
    [Abstract] [Full Text] [Related]

  • 14. Low serum n-3 polyunsaturated fatty acid/n-6 polyunsaturated fatty acid ratio predicts neurological deterioration in Japanese patients with acute ischemic stroke.
    Suda S, Katsumata T, Okubo S, Kanamaru T, Suzuki K, Watanabe Y, Katsura K, Katayama Y.
    Cerebrovasc Dis; 2013 Dec 20; 36(5-6):388-93. PubMed ID: 24248098
    [Abstract] [Full Text] [Related]

  • 15. Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia.
    Mindrescu C, Gupta RP, Hermance EV, DeVoe MC, Soma VR, Coppola JT, Staniloae CS.
    Vasc Health Risk Manag; 2008 Dec 20; 4(6):1439-47. PubMed ID: 19337557
    [Abstract] [Full Text] [Related]

  • 16. Reverse association of omega-3/omega-6 polyunsaturated fatty acids ratios with carotid atherosclerosis in patients on hemodialysis.
    Umemoto N, Ishii H, Kamoi D, Aoyama T, Sakakibara T, Takahashi H, Tanaka A, Yasuda Y, Suzuki S, Matsubara T, Murohara T.
    Atherosclerosis; 2016 Jun 20; 249():65-9. PubMed ID: 27065243
    [Abstract] [Full Text] [Related]

  • 17. Plasma VEGF and IL-8 Levels in Patients with Mixed Dyslipidaemia. Effect of Rosuvastatin Monotherapy or its Combination at a Lower Dose with Omega-3 Fatty Acids: A Pilot Study.
    Chantzichristos VG, Agouridis AP, Moutzouri E, Stellos K, Elisaf MS, Tselepis AD.
    Curr Vasc Pharmacol; 2016 Jun 20; 14(5):474-480. PubMed ID: 27041244
    [Abstract] [Full Text] [Related]

  • 18. Effect of statins on atherogenic serum amyloid A and α1-antitrypsin low-density lipoprotein complexes.
    Miyazaki Y, Katanasaka Y, Sunagawa Y, Hirano-Sunagawa S, Funamoto M, Morimoto E, Komiyama M, Shimatsu A, Satoh-Asahara N, Yamakage H, Wada H, Hasegawa K, Morimoto T.
    Int J Cardiol; 2016 Dec 15; 225():332-336. PubMed ID: 27756037
    [Abstract] [Full Text] [Related]

  • 19. Effects of lipid-lowering therapy with strong statin on serum polyunsaturated fatty acid levels in patients with coronary artery disease.
    Kurisu S, Ishibashi K, Kato Y, Mitsuba N, Dohi Y, Nishioka K, Kihara Y.
    Heart Vessels; 2013 Jan 15; 28(1):34-8. PubMed ID: 22187148
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial.
    Kim CH, Han KA, Yu J, Lee SH, Jeon HK, Kim SH, Kim SY, Han KH, Won K, Kim DB, Lee KJ, Min K, Byun DW, Lim SW, Ahn CW, Kim S, Hong YJ, Sung J, Hur SH, Hong SJ, Lim HS, Park IB, Kim IJ, Lee H, Kim HS.
    Clin Ther; 2018 Jan 15; 40(1):83-94. PubMed ID: 29223557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.